Cedar Brook Financial Partners’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-5,000
| Closed | -$201K | – | 384 |
|
2022
Q3 | $201K | Hold |
5,000
| – | – | 0.06% | 329 |
|
2022
Q2 | $210K | Buy |
+5,000
| New | +$210K | 0.07% | 315 |
|
2021
Q3 | – | Sell |
-5,000
| Closed | -$205K | – | 371 |
|
2021
Q2 | $205K | Hold |
5,000
| – | – | 0.06% | 352 |
|
2021
Q1 | $218K | Hold |
5,000
| – | – | 0.08% | 294 |
|
2020
Q4 | $250K | Buy |
+5,000
| New | +$250K | 0.09% | 254 |
|